Randomized Phase II Trial Evaluating the Addition of

[PDF] Randomized Phase II Study Evaluating Palbociclib in Addition ...

Adding palbociclib to letrozole significantly enhanced the suppression of malignant cell proliferation (Ki-67) in primary ER-positive BC, ...

ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating ...

ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and ...

S2207: RANDOMIZED PHASE II STUDY OF THE ADDITION OF ...

The SWOG 2207 trial will test the addition of tazemetostat or zanubrutinib to the tafa-len backbone in a randomized study open nationwide.

CLINICAL TRIAL PROTOCOL A Phase II, Randomized, Double ...

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate ... In addition, a summary of the clinical trial report will be ...

Randomized Phase II Study Evaluating the Addition of ... - OUCI

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer ... Authors: Atish D.

(PDF) Randomized Phase II Study Evaluating Palbociclib in Addition ...

PALLET is a phase II randomized trial that evaluated the effects of combination palbociclib plus letrozole as neoadjuvant therapy. ... Palbociclib 125 mg/d was ...

Randomized Phase II Trial of Seribantumab in Combination with ...

This open-label, randomized phase 1/2 study evaluated safety and efficacy of seribantumab plus erlotinib in advanced non-small cell lung cancer (NSCLC).

Design, power, and alpha levels in randomized phase II oncology ...

A prior evaluation of reporting in phase II oncology trials found ... In addition, almost one-third of studies (27%) had spin, meaning ...

A Phase II Randomized Controlled Trial of Genomically Directed ...

Five-year OS will be compared between treatment groups using the same methodology as DFS. In addition, characteristics of tumor specimens and genomic DNA will ...

Primary analysis of a prospective, randomized, single-blinded phase ...

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients ...

the CARACAS study | Journal for ImmunoTherapy of Cancer

Randomized phase II trial of avelumab alone or in combination with cetuximab ... In SqNSCLC, in the KEYNOTE-407 trial, adding the anti-PD-1 ...

A phase 2b, randomized, double-blind, placebo-controlled, clinical ...

... evaluation of atacicept. In conclusion, the ORIGIN phase 2b study demonstrates that treatment with atacicept in addition to current standard of care results ...

PARTNER: A randomized, phase II/III trial to evaluate the safety and ...

PARTNER: A randomized, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in patients ...

CHEOPS trial: a GINECO group randomized phase II assessing ...

Background The objective of the CHEOPS trial was to assess the benefit of adding aromatase inhibitor (AI) to metronomic chemotherapy, oral ...

S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With ...

In addition, two other patients had complications: one ... 34. Remon Masip, J. ∙ Bironzo, P. ∙ Girard, N. ... LBA83 - PECATI: a phase II trial to evaluate ...

ASCO GU 2021: Randomized Phase II Study Evaluating ... - UroToday

ASCO GU 2021 Genitourinary Cancers Symposium, Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic ...

Are There Circumstances in Which Phase 2 Study Results Should ...

In addition, when using a time-to-progression endpoint, surveillance ... Optimizing randomized phase II trials assessing tumor progression.

Randomized Phase II Study Evaluating Palbociclib in Addition to ...

combination with endocrine therapy. PALLET is a phase II randomized trial that evaluated the effects of combination palbociclib plus letrozole ...

A randomized phase II trial evaluating the addition of low dose, short ...

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. Ang, Yvonne L. E. and Ho, Gwo ...

ClinicalTrials.gov: Home

Safety continues to be evaluated, and short-term adverse events are studied. ... A phase of research to describe clinical trials that gather more information ...